Copperwynd Financial, LLC Merck & Co., Inc. Transaction History

Copperwynd Financial, LLC

$318 Million
Q2 2024

A detailed history of Copperwynd Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Copperwynd Financial, LLC holds 6,729 shares of MRK stock, worth $772,220. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,729

Previous 6,270 7.32%

Holding current value

$772,220

Previous $827,000 0.73%

% of portfolio

0.26%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$123.8 - $132.96 $56,824 - $61,028	459 Added 7.32%	6,729 $833,000
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $25,479 - $29,688	-225 Reduced 3.46%	6,270 $827,000
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $1.39 Million - $1.51 Million	-13,888 Reduced 68.14%	6,495 $708,000
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $28,208 - $31,326	-274 Reduced 1.33%	20,383 $2.1 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $32,474 - $35,395	-299 Reduced 1.43%	20,657 $2.38 Million
Q1 2023 Apr 28, 2023	SELL	$102.94 - $114.86 $1.86 Million - $2.08 Million	-18,090 Reduced 46.33%	20,956 $2.23 Million
Q4 2022 Feb 02, 2023	BUY	$87.44 - $112.11 $1.61 Million - $2.06 Million	18,362 Added 88.77%	39,046 $4.33 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $18,089 - $20,321	-214 Reduced 1.02%	20,684 $1.78 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $1.12 Million - $1.27 Million	13,399 Added 178.68%	20,898 $1.91 Million
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $68,511 - $76,796	932 Added 14.19%	7,499 $615,000
Q4 2021 Feb 04, 2022	BUY	$72.28 - $90.54 $22,695 - $28,429	314 Added 5.02%	6,567 $503,000
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $17,418 - $19,155	243 Added 4.04%	6,253 $470,000
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $24,327 - $26,908	346 Added 6.11%	6,010 $467,000
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $22,586 - $26,604	-328 Reduced 5.47%	5,664 $437,000
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $26,770 - $29,709	373 Added 6.64%	5,992 $490,000
Q3 2020 Nov 05, 2020	SELL	$73.18 - $82.95 $15,148 - $17,170	-207 Reduced 3.55%	5,619 $466,000
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $48,096 - $54,728	-683 Reduced 10.49%	5,826 $451,000
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $962,311 - $1.33 Million	-15,188 Reduced 70.0%	6,509 $501,000
Q4 2019 Jan 23, 2020	BUY	$77.58 - $87.54 $41,970 - $47,359	541 Added 2.56%	21,697 $1.97 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $147,975 - $161,298	1,945 Added 10.12%	21,156 $1.75 Million
Q2 2019 Aug 07, 2019	BUY	$69.84 - $81.59 $52,100 - $60,866	746 Added 4.04%	19,211 $1.61 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $1.28 Million - $1.47 Million	18,465 New	18,465 $1.54 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $291B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Account

Copperwynd Financial, LLC Merck & Co., Inc. Transaction History